Treatment of cutaneous larva migrans and Toxocara infection

Fundamental and Clinical Pharmacology

Volumn 17, Issue 2, 2003, Pages 213-216

  Caumes, Eric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Albendazole; Cutaneous larva migrans; Ivermectin; Tiabendazole; Toxocariasis

Indexed keywords

ALBENDAZOLE; IMMUNOGLOBULIN E; IVERMECTIN; TIABENDAZOLE;

ANTHELMINTIC ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; FOLLICULITIS; FREEZING; HEADACHE; HELMINTHIASIS; HUMAN; IMMUNOCOMPETENCE; LARVA MIGRANS; MICROFILARIA; NAUSEA; PRIORITY JOURNAL; RASH; TOXOCARIASIS; VERTIGO; VOMITING;

ALBENDAZOLE; ANTINEMATODAL AGENTS; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; HUMANS; IVERMECTIN; LARVA MIGRANS; THIABENDAZOLE; TOXOCARIASIS;

EID: 0037397571     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00172.x     Document Type: Article

References (27)

1. Caumes E. Treatment of cutaneous larva migrans. Clin. Infect. Dis. (2000) 30 811-814.
2. Jelineck T., Maiwald H., Northdurft H.D., Loscher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms and treatment of 98 patients. Clin. Infect. Dis. (1994) 19 1062-1066.
3. Davies H.D., Sakuls P., Keystone J.S. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch. Dermatol. (1993) 129 588-591.
4. Katz R., Hood W.R. Topical tiabendazole for creeping eruption. Arch. Dermatol. (1966) 94 643-645.
5. Davis C.M., Israel R.M. Treatment of creeping eruption with topical tiabendazole. Arch. Dermatol. (1968) 97 325-326.
6. Katz R., Ziegler J., Blank H. The natural course of creeping eruption and treatment with tiabendazole. Arch. Dermatol. (1965) 91 420-424.
7. Stone O.J., Mullins J.F. Tiabendazole effectiveness in creeping eruption. Arch. Dermatol. (1965) 91 427-429.
8. Jacksonville Dermatology Society. Creeping eruption treated with tiabendazole. Arch. Dermatol. (1965) 91 427-429.
9. Vakil B.J., Bandisode M.S., Gaitonde B.B., Salunkhe D.S., Kulkarni H.J. Clinical trials with a new antihelminthic, tiabendazole. J. Trop. Med. Hyg. (1955) 58 287-295.
10. Orihuela A.R., Torres J.R. Single dose of albendazole in the treatment of cutaneous larva migrans. Arch. Dermatol. (1990) 126 398-399.
11. Jones S.K., Reynolds N.J., Oliwiecki S., Harman R.R.M. Oral albendazole for the treatment of cutaneous larva migrans. Br. J. Dermatol. (1990) 122 99-101.
12. Coulaud J.P., Binet D., Voyer C., Samson C., Moreau G., Rossignol J.F. Traitement du syndrome de Larva Migrans cutanée 'larbish' par l'albendazole: à propos de 18 observations. Bull. Soc. Path. Exot. (1982) 75 534-537.
13. Williams H.C., Monk B. Creeping eruption stopped in its track by albendazole. Clin. Exp. Dermatol. (1989) 14 355-356.
14. Sanguigni S., Marangi M., Teggi A., De Rosa F. Albendazole in the therapy of cutaneous Larva migrans. Trans. R. Soc. Trop. Med. Hyg. (1990) 84 831.
15. Caumes E., Carrière J., Datry A., Danis M., Gentilini M. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am. J. Trop. Med. Hyg. (1993) 49 641-644.
16. Louis J.F., De Quincenet G., Louis J.P. Intérêt de l'ivermectine en prise unique dans le traitement du syndrome de Larva migrans cutanée. Presse. Med. (1992) 21 1483.
17. Caumes E., Datry A., Paris L., Danis M., Gentilini M., Gaxotte P. Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch. Dermatol. (1992) 128 994-995.
18. Bouchaud O., Houzé S., Schiemann R. et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin. Infect. Dis. (2000) 31 493-498.
19. Caumes E., Carrière J., Guermonprez G., Bricaire F., Danis M., Gentilini M. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin. Infect. Dis. (1995) 20 542-548.
20. Van Den Enden E., Stevens A., Gompel A.V. Treatment of cutaneous larva migrans. N. Engl. J. Med. (1998) 339 1246-1247.
21. Caumes E., Ly F., Bricaire F. Cutaneous larva migrans with folliculitis: report of seven cases and review of the literature. Br. J. Dermatol. (2002) 146 1-3.
22. Goa K.L., Mc Tavish D., Clissold S.D. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs (1991) 42 640-658.
23. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J. Helminthol. (2001) 75 299-305.
24. Sturchler D., Schubarth P., Gualzata M., Gottstein B., Oettli A. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann. Trop. Med. Parasitol. (1989) 83 473-478.
25. Magnaval J.F. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology (1995) 110 529-533.
26. Barisani-Asenbauer T., Maca S.M., Hauff W. et al. Treatment of ocular toxocariasis with albendazole. J. Ocul. Pharmacol. Ther. (2001) 17 287-294.
27. Magnaval J.F. Apparent weak efficacy of ivermectin for the treatment of human toxocariasis. Antimicrob. Agents Chemother. (1998) 42 2270.